RSS-Feed abonnieren
DOI: 10.1055/s-0031-1297174
Anticoagulation in Children Undergoing Cardiac Surgery
Publikationsverlauf
Publikationsdatum:
20. Dezember 2011 (online)

ABSTRACT
Advances in medical and surgical care have resulted in improved survival of patients with congenital heart disease (CHD). Parallel to these progresses, an increasing number of immediate and long-term complications have been recognized. One important complication in CHD is the development of thrombosis. Children with a single functional cardiac ventricle usually require sequential steps of surgery: the initial Blalock-Taussig shunts (BTS) during the neonatal period, followed by the Glenn shunt, and finally, the Fontan shunt, the “definitive palliative” procedure. Surgery mostly involves cardiopulmonary bypass (CPB), which also affects the coagulation system and causes an inflammatory response. This article will review surgical procedures, such as BTS, Glenn shunt, and Fontan shunt, prosthetic mechanical valves, and CPB, and their risk of thrombotic complications. There is insufficient evidence and no consensus for optimal anticoagulant prophylaxis or treatment in children with CHD. Current recommendations are mostly based on adult data.
KEYWORDS
Pediatric cardiology - cardiac surgery - thrombosis - thromboprophylaxis - anticoagulation
REFERENCES
- 1
Boris J R, Harris M A.
The use of anticoagulation in pediatric cardiac disease.
Images Pediatr Cardiol.
2003;
16
1-35
MissingFormLabel
- 2
Monagle P.
Thrombosis in children with BT shunts, Glenns and Fontans.
Prog Pediatr Cardiol.
2005;
21
17-21
MissingFormLabel
- 3
Monagle P, Adams M, Mahoney M et al..
Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood
Thrombophilia Registry.
Pediatr Res.
2000;
47
(6)
763-766
MissingFormLabel
- 4
Blalock A.
Physiopathology and surgical treatment of congenital cardiovascular defects.
Harvey Lect.
1945–1946;
41
90-116
MissingFormLabel
- 5
Glenn W W.
Circulatory bypass of the right side of the heart. IV. Shunt between superior vena
cava and distal right pulmonary artery; report of clinical application.
N Engl J Med.
1958;
259
(3)
117-120
MissingFormLabel
- 6
Fontan F, Baudet E.
Surgical repair of tricuspid atresia.
Thorax.
1971;
26
(3)
240-248
MissingFormLabel
- 7
Monagle P, Cochrane A, Roberts R et al..
A multicentre randomized trial comparing heparin/warfarin and aspirin as primary thromboprophylaxis
for two years after fontan procedure in children.
J Am Coll Cardiol.
2011;
58
645-651
MissingFormLabel
- 8
Caldarone C A, Raghuveer G, Hills C B et al..
Long-term survival after mitral valve replacement in children aged <5 years: a multi-institutional
study.
Circulation.
2001;
104
(12, Suppl 1)
I143-I147
MissingFormLabel
- 9
Khitin L M, Sade R M, Bradley S M, Crawford Jr F A, Widener C E, Stroud M R.
Prevention of thrombosis and embolism in children and adolescents with mechanical
valve prostheses: warfarin versus antiplatelet agents.
J Heart Valve Dis.
2006;
15
(3)
394-399
discussion 399
MissingFormLabel
- 10
Tamisier D, Vouhé P R, Vernant F, Lecá F, Massot C, Neveux J Y.
Modified Blalock-Taussig shunts: results in infants less than 3 months of age.
Ann Thorac Surg.
1990;
49
(5)
797-801
MissingFormLabel
- 11
Karpawich P P, Bush C P, Antillon J R, Amato J J, Marbey M L, Agarwal K C.
Modified Blalock-Taussig shunt in infants and young children. Clinical and catheterization
assessment.
J Thorac Cardiovasc Surg.
1985;
89
(2)
275-279
MissingFormLabel
- 12
Ahmad U, Fatimi S H, Naqvi I et al..
Modified Blalock-Taussig shunt: immediate and short-term follow-up results in neonates.
Heart Lung Circ.
2008;
17
(1)
54-58
MissingFormLabel
- 13
Norwood W I, Lang P, Hansen D D.
Physiologic repair of aortic atresia-hypoplastic left heart syndrome.
N Engl J Med.
1983;
308
(1)
23-26
MissingFormLabel
- 14
Al Jubair K A, Al Fagih M R, Al Jarallah A S et al..
Results of 546 Blalock-Taussig shunts performed in 478 patients.
Cardiol Young.
1998;
8
(4)
486-490
MissingFormLabel
- 15
Tsai K T, Chang C H, Lin P J.
Modified Blalock-Taussig shunt: statistical analysis of potential factors influencing
shunt outcome.
J Cardiovasc Surg (Torino).
1996;
37
(2)
149-152
MissingFormLabel
- 16
Wells W J, Yu R J, Batra A S, Monforte H, Sintek C, Starnes V A.
Obstruction in modified Blalock shunts: a quantitative analysis with clinical correlation.
Ann Thorac Surg.
2005;
79
(6)
2072-2076
MissingFormLabel
- 17
Moulton A L, Brenner J I, Ringel R et al..
Classic versus modified Blalock-Taussig shunts in neonates and infants.
Circulation.
1985;
72
(3 Pt 2)
II35-II44
MissingFormLabel
- 18
Gladman G, McCrindle B W, Williams W G, Freedom R M, Benson L N.
The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy
in the current era.
J Thorac Cardiovasc Surg.
1997;
114
(1)
25-30
MissingFormLabel
- 19
Karakurt C, Koçak G, Ozgen U.
Recanalization of occluded modified Blalock-Taussig shunt with balloon angioplasty
and intraarterial streptokinase.
Anadolu Kardiyol Derg.
2008;
8
(1)
76-78
MissingFormLabel
- 20
Monagle P, Chalmers E, Chan A American College of Chest Physicians et al.
Antithrombotic therapy in neonates and children: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest.
2008;
133
(6, Suppl)
887S-968S
MissingFormLabel
- 21
LeBlanc J, Albus R, Williams W G et al..
Serous fluid leakage: a complication following the modified Blalock-Taussig shunt.
J Thorac Cardiovasc Surg.
1984;
88
(2)
259-262
MissingFormLabel
- 22
Mullen J C, Lemermeyer G, Bentley M J.
Modified Blalock-Taussig shunts: to heparinize or not to heparinize?.
Can J Cardiol.
1996;
12
(7)
645-647
MissingFormLabel
- 23
Fenton K N, Siewers R D, Rebovich B, Pigula F A.
Interim mortality in infants with systemic-to-pulmonary artery shunts.
Ann Thorac Surg.
2003;
76
(1)
152-156
discussion 156-157
MissingFormLabel
- 24
Motz R, Wessel A, Ruschewski W, Bürsch J.
Reduced frequency of occlusion of aorto-pulmonary shunts in infants receiving aspirin.
Cardiol Young.
1999;
9
(5)
474-477
MissingFormLabel
- 25
Li J S, Yow E, Berezny K Y et al..
Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt
in infants with cyanotic congenital heart disease: does aspirin make a difference?.
Circulation.
2007;
116
(3)
293-297
MissingFormLabel
- 26
Wessel D L, Berger F, Li J S, Fontecave S, Rakhit A, Newburger J W. for the CLARINET Investigators .
A randomized trial of clopidogrel to reduce mortality and shunt-related morbidity
in infants palliated with systemic to pulmonary artery shunt.
Circulation.
2010;
122
A19459
MissingFormLabel
- 27
Tanoue Y, Kado H, Boku N et al..
Three hundred and thirty-three experiences with the bidirectional Glenn procedure
in a single institute.
Interact Cardiovasc Thorac Surg.
2007;
6
(1)
97-101
MissingFormLabel
- 28
Gewillig M.
The Fontan circulation.
Heart.
2005;
91
(6)
839-846
MissingFormLabel
- 29
Pennington D G, Nouri S, Ho J et al..
Glenn shunt: long-term results and current role in congenital heart operations.
Ann Thorac Surg.
1981;
31
(6)
532-539
MissingFormLabel
- 30
Kopf G S, Laks H, Stansel H C, Hellenbrand W E, Kleinman C S, Talner N S.
Thirty-year follow-up of superior vena cava-pulmonary artery (Glenn) shunts.
J Thorac Cardiovasc Surg.
1990;
100
(5)
662-670
discussion 670-671
MissingFormLabel
- 31
Koutlas T C, Harrison J K, Bashore T M, O'Laughlin M P, Tripp M E, Gaynor J W.
Late conduit occlusion after modified Fontan procedure with classic Glenn shunt.
Ann Thorac Surg.
1996;
62
(1)
258-261
discussion 261-262
MissingFormLabel
- 32
Kuroczynski W.
[Development of the Fontan procedure as therapeutic concept for children with complex
congenital heart disease].
Herz.
2007;
32
(3)
241-247
MissingFormLabel
- 33
Kaulitz R, Ziemer G, Luhmer I, Kallfelz H C.
Modified Fontan operation in functionally univentricular hearts: preoperative risk
factors and intermediate results.
J Thorac Cardiovasc Surg.
1996;
112
(3)
658-664
MissingFormLabel
- 34
Lemler M S, Scott W A, Leonard S R, Stromberg D, Ramaciotti C.
Fenestration improves clinical outcome of the fontan procedure: a prospective, randomized
study.
Circulation.
2002;
105
(2)
207-212
MissingFormLabel
- 35
Kaulitz R, Ziemer G, Rauch R et al..
Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary
anastomosis).
J Thorac Cardiovasc Surg.
2005;
129
(3)
569-575
MissingFormLabel
- 36
Cromme-Dijkhuis A H, Henkens C M, Bijleveld C M, Hillege H L, Bom V J, van der Meer J.
Coagulation factor abnormalities as possible thrombotic risk factors after Fontan
operations.
Lancet.
1990;
336
(8723)
1087-1090
MissingFormLabel
- 37
Cromme-Dijkhuis A H, Hess J, Hählen K et al..
Specific sequelae after Fontan operation at mid- and long-term follow-up. Arrhythmia,
liver dysfunction, and coagulation disorders.
J Thorac Cardiovasc Surg.
1993;
106
(6)
1126-1132
MissingFormLabel
- 38
Balling G, Vogt M, Kaemmerer H, Eicken A, Meisner H, Hess J.
Intracardiac thrombus formation after the Fontan operation.
J Thorac Cardiovasc Surg.
2000;
119
(4 Pt 1)
745-752
MissingFormLabel
- 39
Coon P D, Rychik J, Novello R T, Ro P S, Gaynor J W, Spray T L.
Thrombus formation after the Fontan operation.
Ann Thorac Surg.
2001;
71
(6)
1990-1994
MissingFormLabel
- 40
Seipelt R G, Franke A, Vazquez-Jimenez J F et al..
Thromboembolic complications after Fontan procedures: comparison of different therapeutic
approaches.
Ann Thorac Surg.
2002;
74
(2)
556-562
MissingFormLabel
- 41
Chun D S, Schamberger M S, Flaspohler T et al..
Incidence, outcome, and risk factors for stroke after the Fontan procedure.
Am J Cardiol.
2004;
93
(1)
117-119
MissingFormLabel
- 42
Stümper O, Sutherland G R, Geuskens R, Roelandt J R, Bos E, Hess J.
Transesophageal echocardiography in evaluation and management after a Fontan procedure.
J Am Coll Cardiol.
1991;
17
(5)
1152-1160
MissingFormLabel
- 43
Fyfe D A, Kline C H, Sade R M, Gillette P C.
Transesophageal echocardiography detects thrombus formation not identified by transthoracic
echocardiography after the Fontan operation.
J Am Coll Cardiol.
1991;
18
(7)
1733-1737
MissingFormLabel
- 44
Heying R, van Oeveren W, Wilhelm S et al..
Children undergoing cardiac surgery for complex cardiac defects show imbalance between
pro- and anti-thrombotic activity.
Crit Care.
2006;
10
(6)
R165
MissingFormLabel
- 45
Iyer G K, Van Arsdell G S, Dicke F P, McCrindle B W, Coles J G, Williams W G.
Are bilateral superior vena cavae a risk factor for single ventricle palliation?.
Ann Thorac Surg.
2000;
70
(3)
711-716
MissingFormLabel
- 46
Bando K, Turrentine M W, Park H J, Sharp T G, Scavo V, Brown J W.
Evolution of the Fontan procedure in a single center.
Ann Thorac Surg.
2000;
69
(6)
1873-1879
MissingFormLabel
- 47
Mair D D, Puga F J, Danielson G K.
The Fontan procedure for tricuspid atresia: early and late results of a 25-year experience
with 216 patients.
J Am Coll Cardiol.
2001;
37
(3)
933-939
MissingFormLabel
- 48
Petrossian E, Reddy V M, McElhinney D B et al..
Early results of the extracardiac conduit Fontan operation.
J Thorac Cardiovasc Surg.
1999;
117
(4)
688-696
MissingFormLabel
- 49
Giannico S, Santoro G, Marino B, Cicini M P, Marcelletti C.
Bidirectional cavopulmonary anastomosis in congenital heart disease. Functional and
clinical outcome.
Herz.
1992;
17
(4)
234-241
MissingFormLabel
- 50
Shirai L K, Rosenthal D N, Reitz B A, Robbins R C, Dubin A M.
Arrhythmias and thromboembolic complications after the extracardiac Fontan operation.
J Thorac Cardiovasc Surg.
1998;
115
(3)
499-505
MissingFormLabel
- 51
Konstantinov I E, Puga F J, Alexi-Meskishvili V V.
Thrombosis of intracardiac or extracardiac conduits after modified Fontan operation
in patients with azygous continuation of the inferior vena cava.
Ann Thorac Surg.
2001;
72
(5)
1641-1644
MissingFormLabel
- 52
Abid F, Abid A, Fekih M, Zaouali R M, Ben Ismail M.
Aortic valve replacement in children under 16 years of age with congenital or rheumatic
valvular disease. A study of 64 cases.
J Cardiovasc Surg (Torino).
1992;
33
(3)
265-271
MissingFormLabel
- 53
Robbins R C, Bowman Jr F O, Malm J R.
Cardiac valve replacement in children: a twenty-year series.
Ann Thorac Surg.
1988;
45
(1)
56-61
MissingFormLabel
- 54
Eaton M P, Iannoli E M.
Coagulation considerations for infants and children undergoing cardiopulmonary bypass.
Paediatr Anaesth.
2011;
21
(1)
31-42
MissingFormLabel
- 55
Despotis G J, Avidan M S, Hogue Jr C W.
Mechanisms and attenuation of hemostatic activation during extracorporeal circulation.
Ann Thorac Surg.
2001;
72
(5)
S1821-S1831
MissingFormLabel
- 56
Mojcik C F, Levy J H.
Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
Ann Thorac Surg.
2001;
71
(2)
745-754
MissingFormLabel
- 57
Guzzetta N A, Miller B E, Todd K, Szlam F, Moore R H, Tosone S R.
An evaluation of the effects of a standard heparin dose on thrombin inhibition during
cardiopulmonary bypass in neonates.
Anesth Analg.
2005;
100
(5)
1276-1282,table of contents
MissingFormLabel
- 58
Koster A, Fischer T, Praus M et al..
Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact
of heparin management.
Anesthesiology.
2002;
97
(4)
837-841
MissingFormLabel
- 59
Freed M D, Keane J F, Rosenthal A.
The use of heparinization to prevent arterial thrombosis after percutaneous cardiac
catheterization in children.
Circulation.
1974;
50
(3)
565-569
MissingFormLabel
- 60
Saxena A, Gupta R, Kumar R K, Kothari S S, Wasir H S.
Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants
and children randomized to two heparin dosages.
Cathet Cardiovasc Diagn.
1997;
41
(4)
400-403
MissingFormLabel
- 61
Bulbul Z R, Galal M O, Mahmoud E et al..
Arterial complications following cardiac catheterization in children less than 10
kg.
Asian Cardiovasc Thorac Ann.
2002;
10
(2)
129-132
MissingFormLabel
- 62
Grady R M, Eisenberg P R, Bridges N D.
Rational approach to use of heparin during cardiac catheterization in children.
J Am Coll Cardiol.
1995;
25
(3)
725-729
MissingFormLabel
- 63
Girod D A, Hurwitz R A, Caldwell R L.
Heparinization for prevention of thrombosis following pediatric percutaneous arterial
catheterization.
Pediatr Cardiol.
1982;
3
(2)
175-180
MissingFormLabel
- 64
Laurin S, Lundström N R.
Venous thrombosis after cardiac catheterization in infants.
Acta Radiol.
1987;
28
(3)
241-246
MissingFormLabel
- 65
Miga D E, McKellar L F, Denslow S, Wiles H B, Case C L, Gillette P C.
Incidence of femoral vein occlusion after catheter ablation in children: evaluation
with magnetic resonance angiography.
Pediatr Cardiol.
1997;
18
(3)
204-207
MissingFormLabel
- 66
Hanslik A, Kitzmüller E, Thom K, Salzer-Muhar U, Michel-Behnke I, Male C.
Comparison of high-dose vs low-dose heparinization protocols for prophylaxis of thrombotic
complications during cardiac catheterization in children, HEARTCAT Study.
J Thromb Hemost.
2011;
in press
MissingFormLabel
Katharina E. ThomM.D.
Department for Pediatric Cardiology, University Hospital for Children and Adolescent
Medicine
Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
eMail: katharina.thom@meduniwien.ac.at